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A B S T R A C T
Purpose: Patients with intracerebral hemorrhage (ICH) are often initiated on antiepileptic drugs without
a clear indication. We compared the percentage of patients with spontaneous ICH who had seizures at
onset or during hospitalization, and examined empiric use of antiepileptic drugs (AEDs) in these patients
in 2 cohorts 10 years apart.
Methods: Using a clinical data registry at a tertiary care adult hospital, we retrospectively selected
admissions for spontaneous ICH between 1/1/99–12/31/00 (Cohort A, n = 30) and 1/1/09–12/31/10
(Cohort B, n = 108). Clinical, neurophysiological and radiological data were collected in both cohorts.
Results: In Cohorts A and B respectively, AEDs were started in 53.3% and 50.0%, and continued on
discharge in 50.0% and 20.4% of patients; 86.6% and 59.1% of patients discharged on AEDs did not have a
clinical/electrographic seizure or epileptiform EEG ﬁndings. Seizures occurred in 6.6% and 13.0% in
Cohorts A and B respectively. The presence of a seizure at presentation (p = 0.01) and during
hospitalization (p = 0.02) were predictors for continuing AED on discharge.
Conclusion: In both cohorts, a signiﬁcant number of patients were discharged on AEDs without a clear
indication, though there is a change in practice between the two cohorts.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Seizures are an important neurological complication of
spontaneous intracerebral hemorrhage (ICH). In a large clinical
series of 761 consecutive patients, early seizures occurred in 4.2%
of patients, and 8.1% had seizures within 30 days of ICH onset.1
They may be difﬁcult to detect because they are often non-
convulsive in nature.2,3 ICH-related seizures may be associated
with adverse outcomes. However, in another population based
study, the presence of seizures in ICH was not found to be an
independent predictor of poor neurological outcome.4 The latest
AHA/ASA guidelines for management of spontaneous ICH state
that only patients with clinical seizures and those with a change in
mental status who are found to have electrographic seizures on
EEG should be treated with antiepileptic drugs (AEDs).5
Nonetheless, the use of AEDs presents a difﬁcult management
decision. Patients who are admitted to the neurological intensive
care unit (ICU) with spontaneous intracerebral hemorrhage are* Corresponding author. Tel.: +617 732 7547.
E-mail address: jlee38@partners.org (J.W. Lee).
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http://dx.doi.org/10.1016/j.seizure.2013.03.011frequently loaded with or started on AEDs in the emergency
department. Although there may be no clear indication for AED
therapy, a signiﬁcant proportion of patients may nevertheless be
discharged on it. Use of AEDs may be independently associated
with poor outcome in patients with intracerebral hemorrhage6,7
and subarachnoid hemorrhage.8–10 Furthermore, AEDs have not
been demonstrated to prevent epileptogenesis.11,12 Thus, in the
absence of clinical or electrographic seizures, there is insufﬁcient
evidence to support the early use of antiepileptic drugs in patients
with spontaneous parenchymal and intraventricular hemor-
rhages.5
A better understanding of the risk factors of seizures following
intracerebral hemorrhages is needed to predict which patients will
require treatment. In this study, two cohorts 10 years apart were
examined to evaluate changing trends in management, especially
in the setting of recent increased use of EEG monitoring in such
patients. Using these two cohorts, we sought to compare the
percentage of patients with spontaneous ICH, who experienced
clinical or electrographic seizures at onset or during hospitaliza-
tion, the percentage of patients who were started on an AED, and
the percentage of patients discharged on an AED in the absence of a
clinical or electrographic seizure.vier Ltd. All rights reserved.
Table 1
Demographics.
Characteristics 1999–2000
Cohort A
2009–2010
Cohort B
P value
Age (mean  SD) 75.13  11.47 73  13.48 0.82
Women 17 (56.7%) 48 (44.4%) 0.48
Deceased 1 (3%) 17 (16%) 0.12
ICH location
Cortical 20 (66.7%) 45 (41.7%) 0.03
Deep 10 (33.3%) 55 (50.9%)
IVH 0 (0%) 8 (7.4%)
ICH volume
<50 cc 5 (16.7%) 80 (74.1%) 0.18
50 cc 3 (10.0%) 17 (15.8%)
Difﬁcult to assess/not available 22 (73.3%) 11 (10.2%)
Mean (SD) Not available 27.5 (29.6)
Presence of SAH 4 (13.3%) 32 (29.6%) 0.10
Presence of SDH 3 (10.0%) 14 (13.0%) 1.00
Hematoma expansion 3 (10.0%) 19 (17.6%) 0.41
Neurosurgical intervention 10 (33.3%) 27 (25.0%) 0.36
Total patients 30 108
ICH: intracerebral hemorrhage, IVH: intraventricular hemorrhage, SAH: subarach-
noid hemorrhage, SDH: subdural hemorrhage, INR: international normalized ratio,
SD: standard deviation, and cc: cubic centimeters.
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2.1. Patient selection
Using a clinical data registry (Research Patient Data Registry or
RPDR)13 at a tertiary care adult hospital, we retrospectively
selected all admissions for spontaneous intracerebral hemor-
rhages between 1/1/99–12/31/00 (Cohort A), and 1/1/09–12/31/
10 (Cohort B), as identiﬁed by their ICD-9 code. Inclusion criteria
were: greater than or equal to 18 years of age with supratentorial
ICH conﬁrmed on head CT. Patients with vascular malformations
including cavernomas, AVMs and aneurysms, traumatic brain
injury (TBI), primary subarachnoid and subdural hemorrhages,
infratentorial hemorrhages, hemorrhagic infarcts, hemorrhagic
intracranial primary or secondary malignancies, and patients
with a prior history of epilepsy, were excluded retrospectively by
chart review. The RPDR search criteria were deliberately
nonspeciﬁc so as to minimize the chances of inadvertently
excluding eligible patients. As a result, the search was also
expected to capture a large number of ineligible patients, such as
those whose presenting neurological dysfunction was not
primarily ICH despite a small ICH component, or patients who
were primarily treated at other institutions but who had a
subsequent potentially unrelated admission at our institution.
Patients whose goals of care were changed to ‘‘comfort measures
only’’ (CMO) within 5 days of presentation, or those who did not
survive beyond 5 days of hospitalization, were analyzed
separately to prevent confounding since the decision to prophy-
lactically start AEDs may have been affected by their CMO status
and a rational decision to discontinue AEDs on discharge would
not have been made. This study was approved by the Institutional
Review Board.
2.2. Clinical/laboratory variables
The following clinical data were analyzed in both cohorts:
demographics including age and sex, date of admission, seizure
history and neurosurgical intervention. The presence of any
clinical and/or electrographic seizures at presentation, or at any
time prior to discharge, was obtained. We also recorded the use of
antiepileptic drugs during hospitalization and at the time of
discharge.
The subjects were classiﬁed according to hemorrhage
location into cortical, deep and primary intraventricular. The
presence of any associated subdural, subarachnoid and intra-
ventricular extension of the hemorrhage was documented. The
hemorrhage volume was calculated by the ABC/2 formula on the
admission and subsequent CT scans.14 The presence of hemato-
ma expansion and increase in midline shift were documented as
per the radiologist’s report.
Continuous and routine EEGs were recorded digitally using 21
standard scalp electrodes placed according to the international
10–20 system. We recorded the presence of clinical and
electrographic seizures, interictal epileptiform discharges
(spikes, sharp waves), including periodic epileptiform patterns
such as lateralized periodic discharges and generalized periodic
epileptiform discharges.
2.3. Statistical analysis
Categorical variables were compared using chi-square and
Fisher’s exact test. Continuous variables were compared using
Student’s t-test or Wilcoxon rank-sum test depending on data
normality. Logistic regression was used to determine patient
characteristics inﬂuencing AED initiation on admission, and AED
on discharge. These included seizures at presentation, seizuresduring hospitalization, age, sex, location of the hemorrhage in the
temporal region, hematoma expansion and presence of neurosur-
gical intervention. Data were analyzed with the statistical software
SAS version 9.2 (SAS Institute, Cary, NC).
3. Results
3.1. Study cohorts
From January 1999 to December 2000, a total of 199 patients
were admitted with the diagnosis of intracerebral hemorrhage.
After applying the inclusion and exclusion criteria mentioned
above, we excluded 169 patients, and 30 patients were included in
our study (Cohort A). The most common reasons for excluding the
remaining patients were the presence of vascular malformations
on subsequent CT Angiograms, signiﬁcant TBI, infratentorial
hemorrhages and patients admitted to our partner institution
(Massachusetts General Hospital). Between January 2009 and
December 2010, 521 patients with the diagnosis of intracerebral
hemorrhage were admitted. A total of 108 patients were included
in the study (Cohort B). The demographic characteristics of these
two cohorts are described in Table 1. The reasons for excluding the
remainder of the patients were similar to Cohort A. Table 2
summarizes the characteristics of excluded patients in both
cohorts.
3.2. EEGs
In Cohort A, only 2 patients (6.7%) underwent routine EEGs and
no patients underwent continuous EEG monitoring. In Cohort B, 47
(43.5%) patients underwent EEG studies, of which 30 patients had
continuous EEG monitoring over 24 h or more, and 17 patients had
routine EEGs. One patient in Cohort A (3.3%) and 8 patients in
Cohort B (7.4%) were found to have epileptiform activity on the
EEGs. The patient in Cohort A had sharp waves. Of the 8 patients in
Cohort B, 4 had electrographic seizures, 2 had periodic epileptiform
discharges and 2 had epileptiform discharges that were not
periodic.
3.3. Seizures
Seizures occurred in 6.7% (n = 2) and 13.0% (n = 14) of patients
in Cohorts A and B, respectively (Table 3). In Cohort A, 6.7% (n = 2)
Table 2
Excluded patients.
Exclusion criteria 1999–2000
Cohort A
2009–2010
Cohort B
P value
Vascular malformations 21 32 0.08
Infratentorial hemorrhage 23 26 0.01
Early CMO 11 28 1.00
TBI 21 97 0.01
Insufﬁcient data 8 8 0.09
No ICH 7 25 0.42
Hemorrhagic infarct 14 16 0.04
Tumor 12 27 0.86
Received care at another institution 24 63 0.80
Primary SAH/SDH 28 88 0.21
History of epilepsy/AEDs
prior to presentation
0 1 1.00
Venous sinus thrombosis 0 3 0.56
Total patients excluded 169 413
TBI: traumatic brain injury, CMO: comfort measures only, ICH: intracerebral
hemorrhages, and SAH/SDH: subarachnoid hemorrhage/subdural hemorrhage.
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admission. No electrographic seizures were recorded in the 2
patients who underwent routine EEGs. In Cohort B, 9.2% patients
(n = 10) had clinical seizures on presentation and 3.7% (n = 4)
patients had clinical and electrographic seizures during hospital
stay. Of the 42.5% (n = 46) patients in Cohort B who had either
continuous or routine EEGs, only 0.9% (n = 1) patients had
subclinical electrographic seizures.
3.4. AEDs
In Cohort A, 53.3% (n = 16) patients were started on or loaded
with an AED at some point during hospitalization, and 50.0%
(n = 15) were discharged on an AED. In Cohort B, 50.0% (n = 54)
patients were started on an AED, and 20.4% (n = 22) were
discharged on an AED (p = 0.002). Of the patients in Cohort A
who were discharged on an AED, 86.6% did not have a clinical or
electrographic seizure at any point of time between presentation
and discharge, nor did they have any epileptiform ﬁndings on their
EEGs. Similarly, of the patients who were discharged on an AED in
Cohort B, 59.1% did not have a clinical/electrographic seizure or
epileptiform EEG ﬁndings. Some of the reasons for the patients
being discharged on an AED included the presence of ‘sharp
transients’ on their EEGs, cortical location of the ICH, neurosurgical
procedures and a ‘possible clinical seizure’ at presentation.
Reasons were not documented for several patients. Of note, the
percentage of temporal lobe hematomas was 16.6% (n = 5) and 7.4%
(n = 8, p = 0.16) in Cohorts A and B respectively. Within this
subpopulation, AEDs were started in 60% (n = 3) and 75% (n = 6,
p = 1.0), and were continued on discharge in 60% (n = 3) and 37.5%
(n = 3, p = 0.59) in Cohorts A and B respectively.Table 3
Results.
Characteristics 1999–2000 Cohort 
AED started 16 (53.3%) 
EEGs performed (routine + continuous) 2 (2 + 0) (6.7%) 
Clinical seizures on presentation/during admission 2 (6.6%) 
Electrographic seizures during admission 0 (0%) 
Epileptiform activity on EEG 1 (3.3%) 
Discharged on antiepileptic drugs 15 (50.0%) 
Location of hemorrhage in patients
who had seizures
Cortical: 2 (100%), d
Changes in serial CT scans in patients
who had seizures
Stable: 2 (100%), he
expansion: 0 (0%)
EEG: electroencephalogram, AEDs: antiepileptic drugs.Characteristics of the patients who underwent neurosurgical
intervention are outlined in Table 4. The percentage of patients
who had undergone neurosurgery and were discharged on an AED
was higher in Cohort A (80.0% vs 18.5%, p = 0.001).
In patients whose goals of care was changed to CMO within less
than 5 days from presentation, 5 out of 11 (45.4%) patients from
Cohort A and 9 out of 26 (34.6%) of patients from Cohort B were
started on AEDs upon presentation (p = 0.74). None of the patients
from either cohort presented with or developed clinical seizures
during hospitalization. EEG studies were not obtained in most
patients; only one patient in Cohort B received an EEG, which did
not reveal any epileptiform discharges.
3.5. Radiological characteristics
The percentages of cortical and deep ICH were 66.7% (n = 20)
and 33.3% (n = 10) in Cohort A, and 41.7% (n = 46) and 50.9%
(n = 55) in Cohort B. Of all the patients with cortical hematomas
(n = 20) in Cohort A, the percentages of patients with frontal,
temporal, parietal and occipital hematomas accounted for 35.0%
(n = 7), 25.0% (n = 5), 20.0% (n = 4) and 20.0% (n = 4) respectively.
Similarly in Cohort B, the percentages were 28.2% (n = 13), 17.3%
(n = 8), 30.4% (n = 14) and 23.9% (n = 11) respectively.
An overwhelming majority of patients who had seizures in both
cohorts had cortical hemorrhages (Cohort A: 100% and Cohort B:
93.3%). In Cohort A, both patients who seized had stable serial
scans. In Cohort B, of the 15 patients who had clinical or
electrographic seizures, 3 patients had hematoma expansion on
repeat CT scans. Hematoma expansion was determined as per
documentation by the radiologist in the CT scan report.
3.6. Predictors of AED use
In Cohort A, there were no signiﬁcant predictors of patients
started or discharged on AEDs. In Cohort B, there were no
signiﬁcant predictors for starting an AED. However, the presence of
a seizure at presentation (p = 0.02) and during hospitalization
(p = 0.04) were found to be signiﬁcant predictors for discharging a
patient on an AED. Also in Cohort B, temporal location of the
hemorrhage, (p = 0.07) showed a trend toward being a signiﬁcant
predictor for AEDs continued on discharge.
When both cohorts were combined together, the presence of a
seizure during hospitalization (p = 0.04) and surgical intervention
(p = 0.03) were both independent signiﬁcant predictors for AED
being started. On the other hand, the presence of a seizure at
presentation (p = 0.01) and during hospitalization (p = 0.02) were
independent signiﬁcant predictors for continuing AED on dis-
charge. When cohort membership was used as an independent
variable, it was found to be a signiﬁcant predictor (p = 0.0003) for
AED continuation on discharge.A 2009–2010 Cohort B P value
54 (50.0%) 0.84
47 (17 + 30) (43.5%) 0.0001
14 (13.0%) 0.52
4 (3.7%) 0.58
8 (7.4%) 0.68
22 (20.4%) 0.002
eep: 0 Cortical: 14 (93.3%), deep: 1 (6.7%) 1.00
matoma Stable: 12 (80.0%), hematoma
expansion: 3 (20.0%)
1.00
Table 4
Neurosurgical patients.
Characteristics 1999–2000 Cohort A 2009–2010 Cohort B P value
Neurosurgical interventiona 10/30 (33.3%) 27/108 (25.0%) 0.36
Started on AEDs 9/10 (90.0%) 16/27 (59.3%) 0.12
Clinical or electrographic seizures on presentation/during admission 1/10 (10.0%) 1/27 (3.7%) 0.47
Discharged on AEDs 8/10 (80.0%) 5/27 (18.5%) 0.001
a Includes patients who underwent external ventricular drain placement or craniotomies.
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This is a retrospective study of 2 cohorts of 30 and 108 patients,
with spontaneous intracerebral hemorrhage, in whom we studied
the incidence of clinical and electrographic seizures, and the use
AEDs during hospitalization and upon discharge. The frequency of
seizures in our study is similar to other studies, which has ranged
from 2.8% to 18% and as high as 19% in more recent studies which
have involved continuous EEG monitoring in all of their patients.15
In our study, seizures occurred at the rate of 6.7% and 13% in
Cohorts A and B, respectively.
We found that a signiﬁcant proportion of patients were being
started on an AED in the absence of clearly identifying clinical
indications in both cohorts. Our study demonstrates a change in
practice in the management of hemorrhage-related seizures within
a 10-year period. Although AEDs were initiated in patients at similar
rates, signiﬁcantly fewer patients were discharged on AEDs in
Cohort B (2009–2010) as compared to Cohort A (1999–2000). This
may be due to several reasons. The AHA guidelines published in
1999, state that prophylactic antiepileptic therapy in patients with
ICH may be considered for a month and then tapered and
discontinued if no seizures occurred during treatment.16 This may
have inﬂuenced the more frequent use of AEDs in Cohort A (January
1999–December 2000). The subsequent publication of the American
Heart Association clinical guidelines for the management of
spontaneous intracerebral hemorrhage in 2007, which recom-
mended against prophylactic use of AEDs,17 may have altered AED
management practices more recently. There was also a marked
increase in the use of EEGs in Cohort B, which also likely led to the
discontinuation of AEDs in patients who may otherwise have been
discharged on them. This change occurred despite the widespread
introduction of less toxic modern AEDs, particularly levetiracetam,
replacing phenytoin, during this time at our institution.18
The optimal use of AEDs in patients with intracerebral
hemorrhages remains to be determined. ICH-related seizures are
associated with higher NIHSS scores, increasing midline shift, and a
trend toward poor outcome, although it is not clear whether there
is a causative effect of seizures or whether seizures are merely
markers of greater injury.2,3 On the other hand, there are other
prospective and population based studies that have shown that
clinical seizures in ICH are not an independent predictor of poor
neurological outcome or mortality.4,19 In a recent clinical trial,
prophylactic use of valproic acid in non-traumatic, non-aneurys-
mal spontaneous intracerebral hemorrhage was associated with a
trend toward decreasing early seizures (<14 days post-event) as
well as improved NIHSS scores at one year, though it did not reduce
the incidence of later seizures.12
Frequent unwarranted use of AEDs can put patients at a high
risk for adverse drug reactions, increased sedation, and unneces-
sary ﬁnancial burden to the patient as well as healthcare in general.
In a retrospective study of patients with ICH, prophylactic AED use
(predominantly phenytoin) was associated with an independent
poor outcome at 90 days.6,7 Other studies have shown similar
results in patients with subarachnoid hemorrhages.8–10
The retrospective nature of this study necessarily limits its
interpretation. The size of the ﬁrst cohort is markedly smaller than
the second, which may be due to a number of reasons. Theneuroscience ICU at our institution doubled in capacity in the last
ten years, which was equal to the time gap between the 2 cohorts.
In addition, the RPDR query may have found a greater number of
patients in the more recent Cohort B due to a more widespread use
of electronic medical records and more accurate coding as
compared to Cohort A. However, the baseline characteristics
between the two cohorts are similar, and there does not appear to
be a selection bias. The two cohorts are similar in most aspects of
demographics, except for the location of the hemorrhage. A larger
percentage of cortical hemorrhages (66.6%) were noted in Cohort
A, as compared to Cohort B (41.6%). No clear explanation for this
was found. We also did not ﬁnd a signiﬁcant association between
hematoma expansion and seizure frequency, possibly due to the
relatively small number of patients who experienced seizures. Our
cohorts most likely under represent the incidence of electrographic
seizures in patients with spontaneous ICH, as the majority of
patients in Cohort A, and more than 50% of patients in Cohort B did
not undergo continuous EEG monitoring. This study was not
designed with an aim to assess the outcomes of patients upon
discharge and beyond, and it is therefore unclear whether the
reduction in AED use conferred any clinical beneﬁt.
The AHA guidelines1 advising against prophylactic treatment
with AEDs was introduced during 2010 as our data was being
collected, possibly biasing the results of Cohort B. However, the
guidelines were released in September 2010, and we do not expect
that practice would have shifted. We have veriﬁed our data to ensure
that the patients admitted after the publication of the article were
not less likely to be started on AEDs; 9 out of 16 patients admitted
after September 2010 were started on AEDs, including 7 out of 14
who did not present with seizures at onset. A further study
comparing a 2 year cohort after 2010 is strongly warranted.
5. Conclusion
Nevertheless, our study has demonstrated further need for
consistent management of seizures and AEDs in these patients.
Therefore, a more rational approach, with greater early use of
continuous EEG monitoring, may result in both overall reduction in
AED use while appropriately treating patients with subclinical
seizures. Further studies of such clinical protocols need to be
investigated.
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